InvestorsHub Logo
Followers 33
Posts 5038
Boards Moderated 4
Alias Born 04/05/2017

Re: Biotech_Tradez post# 24273

Tuesday, 01/23/2018 11:44:04 PM

Tuesday, January 23, 2018 11:44:04 PM

Post# of 33257
Please tell me in what PR states that?
The corporate update PR states "...upon the redesign of its tPEMF devices for use in CNS disorders."

They have 3 concussion clinicals planned. You are most likely correct about the Theracap technology being redesigned and used in them. But that may apply to 2 of the 3.

The Theracap clinical trial was all setup and ready to go.
Did RGN discover something flawed with it? Did ENDV find something flawed with it during negotiations?

I will admit, when I saw it, it looks like a hokey invention.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENDV News